Warren H. Capell

Rivaroxaban in Peripheral Artery Disease after Revascularization

Marc P. Bonaca, Rupert Bauersachs, Sonia S. Anand et al. · New England Journal of Medicine · 2020 · 980 citations · Full text

Medicine, Pharmacotherapy, Surgery +15

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)

Warren H. Capell, Marc P. Bonaca, Mark R. Nehler et al. · American Heart Journal · 2018 · 132 citations

Medicine, Perioperative Medicine, Surgery +13

Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization

William R. Hiatt, Marc P. Bonaca, Manesh R. Patel et al. · Circulation · 2020 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Compositional Differences of LDL Particles in Normal Subjects With LDL Subclass Phenotype A and LDL Subclass Phenotype B

Warren H. Capell, Alberto Zambon, Melissa A. Austin et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1996 · 100 citations

Life Sciences, Biochemistry, Cardiology +15

Short-Term Triglyceride Lowering With Fenofibrate Improves Vasodilator Function in Subjects With Hypertriglyceridemia

Warren H. Capell, Christopher A. DeSouza, Paul Poirier et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 84 citations · Full text

Medicine, Cardiology, Pharmacology +17